Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-06-14 4:34 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Point72 Asset Management L.P. | 3,225,250 5.7% | 3,225,250 (New Position) | View |
| 2024-06-06 6:49 pm Sale | 13D | Olema Pharmaceuticals Inc. OLMA | Logos Global Management LP | 3,248,818 5.8% | -1,018,130 (-23.86%) | View |
| 2024-03-22 4:31 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Deep Track Capital LP | 3,040,248 5.44% | 3,040,248 (New Position) | View |
| 2024-02-14 4:08 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Paradigm Biocapital Advisors LP | 7,903,600 14.3% | 100,000 (+1.28%) | View |
| 2024-02-14 3:08 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Cormorant Asset Management LP | 2,456,800 4.49% | 374,800 (+18.00%) | View |
| 2024-02-14 12:53 pm Sale | 13G | Olema Pharmaceuticals Inc. OLMA | Kynam Capital Management LP | 0 0% | -2,025,234 (Position Closed) | View |
| 2024-02-12 12:21 pm Sale | 13G | Olema Pharmaceuticals Inc. OLMA | JANUS HENDERSON GROUP PLC JHG | 700,100 1.3% | -2,357,206 (-77.10%) | View |
| 2024-01-29 5:25 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | BlackRock Inc. BLK | 3,263,907 6% | 1,958,403 (+150.01%) | View |
| 2023-11-27 5:39 pm Purchase | 13D | Olema Pharmaceuticals Inc. OLMA | Logos Global Management LP | 4,266,948 7.8% | 508,130 (+13.52%) | View |
| 2023-09-14 4:23 pm Purchase | 13D | Olema Pharmaceuticals Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 9,135,893 16.7% | 1,724,390 (+23.27%) | View |
| 2023-09-13 5:22 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Paradigm Biocapital Advisors LP | 7,803,600 14.3% | 5,288,489 (+210.27%) | View |
| 2023-04-10 4:33 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Paradigm Biocapital Advisors LP | 2,515,111 6.2% | 2,515,111 (New Position) | View |
| 2023-03-21 5:40 pm Sale | 13G | Olema Pharmaceuticals Inc. OLMA | Kynam Capital Management LP | 2,025,234 5% | -38,398,598 (-94.99%) | View |
| 2023-02-14 3:45 pm Sale | 13G | Olema Pharmaceuticals Inc. OLMA | Fairmount Funds Management LLC | 0 0% | -2,107,873 (Position Closed) | View |
| 2023-02-14 3:08 pm Sale | 13G | Olema Pharmaceuticals Inc. OLMA | Cormorant Asset Management LP | 2,082,000 5.15% | -87,871 (-4.05%) | View |
| 2023-02-10 1:18 pm Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | Kynam Capital Management LP | 40,423,832 5% | 40,423,832 (New Position) | View |
| 2023-02-10 11:26 am Purchase | 13G | Olema Pharmaceuticals Inc. OLMA | JANUS HENDERSON GROUP PLC JHG | 3,057,306 7.6% | 61,866 (+2.07%) | View |
| 2023-02-09 11:27 am Sale | 13G | Olema Pharmaceuticals Inc. OLMA | VANGUARD GROUP INC | 1,475,350 3.65% | -673,703 (-31.35%) | View |
| 2023-02-06 2:56 pm Sale | 13G | Olema Pharmaceuticals Inc. OLMA | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -2,019,109 (Position Closed) | View |
| 2022-11-14 4:43 pm Unchanged | 13G | Olema Pharmaceuticals Inc. OLMA | RA CAPITAL MANAGEMENT L.P. | 0 0% | 0 (Unchanged) | View |